Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantationThomas J Nevill, John D Shepherd, Heather J Sutherland, et al.
Leukemia Research|September 3, 2008
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levelsDonna L Forrest, Shannon Trainor, Ryan R Brinkman, et al.
Stem Cell Reviews and Reports|June 5, 2025
Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre ExperienceJowon L Kim, Moss A Bruton Joe, Shanee Chung, et al.
Blood|May 5, 2005
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in VancouverJulye C Lavoie, Joseph M Connors, Gordon L Phillips, et al.
Leukemia & Lymphoma|December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
European Journal of Haematology|February 5, 2022
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohortRyan J Stubbins, Maria Stamenkovic, Claudie Roy, et al.
British Journal of Haematology|May 30, 2012
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohortCynthia L Toze, Chinmay B Dalal, Thomas J Nevill, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
British Journal of Haematology|May 10, 2018
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximabKatie Y Zhu, Kevin W Song, Joseph M Connors, et al.
Blood|August 21, 2008
Thalidomide and rituximab in Waldenstrom macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Pageof 4